Skip to main content
# Title Department Research Year
91 COVID-19 associated Mucormycosis among ICU patients: risk factors, control, and challenges 2023
92 Discovery of new 5-substituted-indole-2-carboxamides as dual epidermal growth factor receptor (EGFR)/cyclin dependent kinase-2 (CDK2) inhibitors with potent antiproliferative action Department of Pharmaceutical Organic Chemistry 2023
93 Selective detection of rutin at novel pyridinic-nitrogen-rich carbon dots derived from chicken feet biowaste: The role of bovine serum albumin during the assay Department of Pharmaceutical Analytical Chemistry 2023
94 New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity Department of Pharmaceutical Organic Chemistry 2023
95 Discovery and optimization of 2,3-diaryl-1,3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity Department of Pharmaceutical Organic Chemistry 2023
96 Synthesis, biological evaluation and molecular docking study of some new 4-aminosalicylic acid derivatives as anti-inflammatory and antimycobacterial agents Department of Pharmaceutical Organic Chemistry 2023
97 Chitosan-capped silver nanoparticles with potent and selective intrinsic activity against the breast cancer cells Department of Industrial Pharmacy 2023
98 Phage therapy, a salvage treatment for multidrug-resistant bacteria causing infective endocarditis 2023
99 Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides as Potential Multi-Target Antiproliferative Agents Department of Pharmaceutical Organic Chemistry 2023
100 Ratiometric fluorometric determination of sulfide using graphene quantum dots and self‑assembled thiolate‑capped gold nanoclusters triggered by aluminum Department of Pharmaceutical Analytical Chemistry 2023